NVO
Novo-Nordisk A/S
stockNYSEADR
Market OpenOct 6, 2026 2:30:50 PM EDT
37.17USD-0.999%(-0.37)7,913,915
37.16Bid37.17Ask0.01SpreadPre-marketOct 6, 2026 9:29:30 AM EDT
37.37USD-0.453%(-0.17)
Loading…
Loading…
164.17B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$37.54
Beta
1.05
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$44.46
SMA 200
$45.59
Avg. Vol 10D
15.70M
Avg. Vol 30D
13.16M
Avg. Vol 90D
12.70M
Relative Vol
0.57
4.42B
3.17B
71.86%
26,339,706
0.83%
2.92
54%/46%
48.00%
27.13%
0.3700%
10,000,000
13,000
149,184
637,798
Nov 4, 2026 (29d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 6, 2026
Oct 5, 2026
Novo Nordisk A/S – Share repurchase programme · 
GlobeNewswire Inc.
Oct 4, 2026
Better High-Yield Dividend Stock: Pfizer or Novo Nordisk? · 
The Motley Fool
Oct 2, 2026
Anthropic funds $100M academy to train deployed AI engineers · 
Business Insider
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.31 | 2026-09-29 | -2.95% | 1.533 |
| 1M | 45.16 | 2026-09-08 | -17.67% | -0.404 |
| 3M | 49.26 | 2026-07-06 | -24.52% | -0.276 |
| 6M | 36.67 | 2026-04-06 | +1.39% | 0.234 |
| 1Y | 59.65 | 2025-10-06 | -37.67% | 1.046 |
| 2Y | 117.77 | 2024-10-07 | -68.43% | — |
| 5Y | 48.28 | 2021-10-06 | -22.98% | 0.674 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $37.18, and today's volume is 7,484,372. NVO is down 0.959% today. The 30 day average volume is 13.16M. NVO market cap is $164.17B with 4.42B shares outstanding.